Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Y Dodd

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Transfusion|September 8, 2025
Incidence and window period residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2017 to 2023: The transfusion-transmissible infections monitoring systemEmilya Huseynova, James Haynes, Edward P Notari, et al.
Transfusion|June 22, 2007
Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006)Anne F Eder, Jean M Kennedy, Beth A Dy, et al.
Transfusion|September 2, 2020
Prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion-Transmissible Infections Monitoring System (TTIMS)Whitney R Steele, Roger Y Dodd, Edward P Notari, et al.
Transfusion|June 29, 2016
Motivations for donating and attitudes toward screening policies in US blood donors with viral infectionFarnaz Vahidnia, Susan L Stramer, Debra Kessler, et al.
Transfusion|June 14, 2012
Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st centurySimone A Glynn, Michael P Busch, Roger Y Dodd, et al.
The New England Journal of Medicine|December 14, 2016
Screening for Babesia microti in the U.S. Blood SupplyErin D Moritz, Colleen S Winton, Laura Tonnetti, et al.
Transfusion|January 18, 2021
HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12-month deferral policy for men who have sex with menWhitney R Steele, Roger Y Dodd, Edward P Notari, et al.
The New England Journal of Medicine|May 10, 2018
Investigational Testing for Zika Virus among U.S. Blood DonorsPaula Saá, Melanie Proctor, Gregory Foster, et al.
Transfusion|December 24, 2005
Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004Chyang T Fang, Linda A Chambers, Jean Kennedy, et al.
Vox Sanguinis|June 4, 2025
An international survey on measures to prevent transfusion-transmitted infectious diseases-study results 2: Testing and donor vigilanceGalen Conti, Jay Epstein, Silvano Wendel, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Transfusion|September 8, 2025
Incidence and window period residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2017 to 2023: The transfusion-transmissible infections monitoring systemEmilya Huseynova, James Haynes, Edward P Notari, et al.
Transfusion|June 22, 2007
Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006)Anne F Eder, Jean M Kennedy, Beth A Dy, et al.
Transfusion|September 2, 2020
Prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion-Transmissible Infections Monitoring System (TTIMS)Whitney R Steele, Roger Y Dodd, Edward P Notari, et al.
Transfusion|June 29, 2016
Motivations for donating and attitudes toward screening policies in US blood donors with viral infectionFarnaz Vahidnia, Susan L Stramer, Debra Kessler, et al.
Transfusion|June 14, 2012
Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st centurySimone A Glynn, Michael P Busch, Roger Y Dodd, et al.
The New England Journal of Medicine|December 14, 2016
Screening for Babesia microti in the U.S. Blood SupplyErin D Moritz, Colleen S Winton, Laura Tonnetti, et al.
Transfusion|January 18, 2021
HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12-month deferral policy for men who have sex with menWhitney R Steele, Roger Y Dodd, Edward P Notari, et al.
The New England Journal of Medicine|May 10, 2018
Investigational Testing for Zika Virus among U.S. Blood DonorsPaula Saá, Melanie Proctor, Gregory Foster, et al.
Transfusion|December 24, 2005
Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004Chyang T Fang, Linda A Chambers, Jean Kennedy, et al.
Vox Sanguinis|June 4, 2025
An international survey on measures to prevent transfusion-transmitted infectious diseases-study results 2: Testing and donor vigilanceGalen Conti, Jay Epstein, Silvano Wendel, et al.
Pageof 13